Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 5Completed 3Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 668Neoplasms 585Colorectal Neoplasms 289Carcinoma, Non-Small-Cell Lung 287Prostatic Neoplasms 277Lung Neoplasms 219Melanoma 159Multiple Myeloma 149Neoplasm Metastasis 147Head and Neck Neoplasms 142Pancreatic Neoplasms 140Ovarian Neoplasms 129Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 120Brain Neoplasms 114Squamous Cell Carcinoma of Head and Neck 110Colonic Neoplasms 109Uterine Cervical Neoplasms 107Recurrence 103Stomach Neoplasms 102Lymphoma 100Glioblastoma 91Lymphoma, Non-Hodgkin 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 78Hematologic Neoplasms 78Urinary Bladder Neoplasms 77Lymphoma, Follicular 77Parkinson Disease 4, Autosomal Dominant Lewy Body 74Glioma 73Sarcoma 71

Interventions

maltodextrin 1drospirenone and ethinyl estradiol combination 1Inulin 1Inositol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × 1 year × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

NCT03819140 2025-11-14

CCOUP

University of California, San Francisco

Phase 4 Completed
51 enrolled 15 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT07161440 2025-09-08

PCOSLCMS

Istanbul University

Completed
56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡